BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17894068)

  • 1. Efficacy of dantrolene sodium in the treatment of spasticity.
    Chipman M; Kaul S; Lambie M
    Dis Nerv Syst; 1974 Sep; 35(9):427-31. PubMed ID: 17894068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiologic mechanisms of hemiplegic and paraplegic spasticity: implications for therapy.
    Herman R; Freedman W; Mayer N
    Arch Phys Med Rehabil; 1974 Aug; 55(8):338-43. PubMed ID: 4368954
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
    Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
    Meythaler JM; Guin-Renfroe S; Johnson A; Brunner RM
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmaco--physiology of dantrolene sodium.
    Herman R; Mayer N; Mecomber SA
    Am J Phys Med; 1972 Dec; 51(6):296-311. PubMed ID: 4564128
    [No Abstract]   [Full Text] [Related]  

  • 6. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Jan; 13(1):3-23. PubMed ID: 318989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dantrolene in juvenile spasticity: 3 months of daily observation].
    Berruti P
    Riv Neurol; 1979; 49(1):30-52. PubMed ID: 451397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dantrolene sodium: long-term effects in patients with muscle spasticity.
    Joynt RL
    Arch Phys Med Rehabil; 1976 May; 57(5):212-7. PubMed ID: 776122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of Dantrium on spasticity in paraplegic and tetraplegic patients (author's transl)].
    van Laere M; Leus P; Mastelinck C
    J Belge Med Phys Rehabil; 1978; 1(2):189-99. PubMed ID: 757420
    [No Abstract]   [Full Text] [Related]  

  • 10. Dantrolene sodium for treatment of spasticity.
    Med Lett Drugs Ther; 1974 Jul; 16(15):61-2. PubMed ID: 4843632
    [No Abstract]   [Full Text] [Related]  

  • 11. Dantrolene sodium: long-term effects in severe spasticity.
    Chyatte SB; Basmajian JV
    Arch Phys Med Rehabil; 1973 Jul; 54(7):311-5. PubMed ID: 4577936
    [No Abstract]   [Full Text] [Related]  

  • 12. Dantrolene: new indication. Cerebral palsy in children: uncertain clinical benefit.
    Prescrire Int; 2008 Dec; 17(98):237. PubMed ID: 19422149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical assessment and pharmacologic therapy of spasticity.
    Pedersen E
    Arch Phys Med Rehabil; 1974 Aug; 55(8):344-54. PubMed ID: 4277407
    [No Abstract]   [Full Text] [Related]  

  • 14. Spasticity and the effect of dantrolene sodium.
    Monster AW
    Arch Phys Med Rehabil; 1974 Aug; 55(8):373-83. PubMed ID: 4605132
    [No Abstract]   [Full Text] [Related]  

  • 15. Objective assessment of spasticity, strength, and function with early exhibition of dantrolene sodium after cerebrovascular accident: a randomized double-blind study.
    Katrak PH; Cole AM; Poulos CJ; McCauley JC
    Arch Phys Med Rehabil; 1992 Jan; 73(1):4-9. PubMed ID: 1729971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity].
    Ladd HW; Gingras G; Boucher J; Kazdan N; Keenan R
    Union Med Can; 1973 May; 102(5):1087-92. PubMed ID: 4576244
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of a muscle relaxant: dantrolene sodium (Dantrium).
    Dykes MH
    JAMA; 1975 Feb; 231(8):862-4. PubMed ID: 1089167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of spasticity with dantrolene sodium.
    Mayer N; Necomber SA; Herman R
    Am J Phys Med; 1973 Feb; 52(1):18-29. PubMed ID: 4685519
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantification of the effects of muscle relaxant drugs in man by tonic stretch reflex.
    Meyer M; Adorjáni C
    Adv Neurol; 1983; 39():997-1011. PubMed ID: 6660131
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of dantrolene sodium on pyramidal hypertonia. Clinico-electrophysiological study].
    Caruso G; Fels A; Santoro L; Perretti A
    Acta Neurol (Napoli); 1977; 32(6):872-83. PubMed ID: 343514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.